Using a mobile device to assess heart conditions in emergency departments
Discovery Study of Using a Magnetocardiography (MCG) Device at Emergency Departments (EDs)
This study is testing if a new mobile heart monitoring device can help doctors quickly and accurately check for heart problems in emergency room patients with chest pain.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | SB Technology, Inc. Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06095557 on ClinicalTrials.gov |
What this trial studies
This prospective discovery study aims to evaluate the feasibility of utilizing an unshielded, mobile magnetocardiography (MCG) device in emergency department settings. The primary focus is to determine if interpretable data can be reliably collected during standard emergency workflows for patients presenting with symptoms of Acute Coronary Syndrome (ACS). The study will involve patients who can provide written consent and will exclude those with specific heart conditions or clear non-ischemic causes for their symptoms. The goal is to enhance diagnostic capabilities in emergency care.
Who should consider this trial
Good fit: Ideal candidates are patients presenting to the emergency department with symptoms indicative of Acute Coronary Syndrome.
Not a fit: Patients presenting with ST-Elevation Myocardial Infarction, Atrial Fibrillation, or those with clear non-ischemic causes for their symptoms will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the speed and accuracy of diagnosing Acute Coronary Syndrome in emergency settings.
How similar studies have performed: While the use of mobile MCG devices is relatively novel, similar studies in other diagnostic technologies have shown promise in improving emergency care outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Presents to ED with symptoms of Acute Coronary Syndrome (ACS) * Can provide written consent Exclusion Criteria: * Presents to ED with ST-Elevation Myocardial Infarction (STEMI) * Presents to ED with Atrial Fibrillation * Clear non-ischemic cause for symptoms (i.e. trauma) * Active thoracic metal implants
Where this trial is running
New York, New York
- Icahn School of Medicine at Mount Sinai — New York, New York, United States (Recruiting)
Study contacts
- Study coordinator: Maggie LeDang
- Email: clinical-trials@sandboxquantum.com
- Phone: 408-981-8754
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.